## Core Concept
Apnea in preterm babies refers to the cessation of breathing for more than 20 seconds or accompanied by bradycardia or oxygen desaturation. Preterm infants are prone to apnea due to immaturity of their respiratory control mechanisms. The primary concern with apnea in preterm infants is the potential for significant hypoxemia and bradycardia.

## Why the Correct Answer is Right
The correct answer is related to the characteristics and management of apnea in preterm babies. Typically, options that describe apnea of prematurity (AOP) being a common issue, associated with immature respiratory control, and managed with interventions like caffeine or positive pressure ventilation, are accurate. Without the specific details of the options, we focus on general principles: AOP is treated with methylxanthines (like caffeine), which stimulate the respiratory centers, and with supportive care.

## Why Each Wrong Option is Incorrect
- **Option A:** If this option inaccurately describes a characteristic of apnea in preterm babies, such as suggesting it is not a significant concern or misrepresenting its pathophysiology, it would be incorrect.
- **Option B:** Similarly, if this option provides incorrect information about the causes, effects, or management strategies for apnea in preterm infants, it would be wrong.
- **Option C:** This option would be incorrect if it misrepresents current understanding or practices related to apnea of prematurity.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **caffeine therapy** is a common and effective treatment for apnea of prematurity. It works by blocking adenosine receptors in the brain, which helps stimulate breathing. This is a high-yield fact for exams.

## Correct Answer: D.